Omicron science, good news
New science explains South Africa's low rates of omicron severe disease
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1
https://www.medrxiv.org/content/10.1101/2021.12.27.21268278v1
Institute of Infectious Disease and Molecular Medicine, University of Cape Town
SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations
These contribute to escape from the neutralizing antibody responses,
reducing vaccine protection from infection
We assessed the ability of T cells to react with Omicron spike
In participants who were vaccinated with Ad26.CoV2.S (J and J) (n = 20)
or BNT162b2 (Pfizer) (n = 15
or in unvaccinated convalescent COVID-19 patients (n = 15)
SARS-CoV-2-specific T cells play a key role in modulating COVID-19 severity and provide protective immunity
Results
70-80% of the CD4 and CD8 T cell response to spike was maintained across study groups
The magnitude of Omicron cross-reactive T cells was similar to that of the Beta and Delta variants
These results demonstrate that,
despite Omicron’s extensive mutations
and reduced susceptibility to neutralizing antibodies,
the majority of T cell response,
induced by vaccination or natural infection, cross- recognises the variant.
Well-preserved T cell immunity to Omicron,
is likely to contribute to protection from severe COVID-19,
supporting early clinical observations from South Africa.
Further explanation
The limited effect of Omicron’s mutations on the T cell response suggests that vaccination or prior infection may still provide substantial protection from severe disease.
Indeed, South Africa has reported a lower risk of hospitalisation and severe disease compared to the previous Delta wave
Cross-reactive T cell responses acquired through vaccination or infection may contribute to these apparent milder outcomes for Omicron.
The resilience of the T cell response demonstrated here also bodes well in the event that more highly mutated variants emerge in the future.
Видео Omicron science, good news канала Dr. John Campbell
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1
https://www.medrxiv.org/content/10.1101/2021.12.27.21268278v1
Institute of Infectious Disease and Molecular Medicine, University of Cape Town
SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations
These contribute to escape from the neutralizing antibody responses,
reducing vaccine protection from infection
We assessed the ability of T cells to react with Omicron spike
In participants who were vaccinated with Ad26.CoV2.S (J and J) (n = 20)
or BNT162b2 (Pfizer) (n = 15
or in unvaccinated convalescent COVID-19 patients (n = 15)
SARS-CoV-2-specific T cells play a key role in modulating COVID-19 severity and provide protective immunity
Results
70-80% of the CD4 and CD8 T cell response to spike was maintained across study groups
The magnitude of Omicron cross-reactive T cells was similar to that of the Beta and Delta variants
These results demonstrate that,
despite Omicron’s extensive mutations
and reduced susceptibility to neutralizing antibodies,
the majority of T cell response,
induced by vaccination or natural infection, cross- recognises the variant.
Well-preserved T cell immunity to Omicron,
is likely to contribute to protection from severe COVID-19,
supporting early clinical observations from South Africa.
Further explanation
The limited effect of Omicron’s mutations on the T cell response suggests that vaccination or prior infection may still provide substantial protection from severe disease.
Indeed, South Africa has reported a lower risk of hospitalisation and severe disease compared to the previous Delta wave
Cross-reactive T cell responses acquired through vaccination or infection may contribute to these apparent milder outcomes for Omicron.
The resilience of the T cell response demonstrated here also bodes well in the event that more highly mutated variants emerge in the future.
Видео Omicron science, good news канала Dr. John Campbell
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Natural versus vaccine immunityHeart risk after vaccinesChina, zero covidVitamin D in IsraelUS hospital patient remain highVitamin D levels advisedDebunking the BBC debunk of ivermectinOmicron from miceMouth wash, Colchicine and Vitamin DPre-infection adviceInternational data agreesVaccination advice in the age of omicronDr Cohen and ironOmicron growth for next two weeksSpecialists now agree on endemic endingFever, Fluids, Food in acute infectionsBoosters for all adults, conflicting adviceOmicron, Common cold symptomsImportant Long Covid informationOmicron, orientation and unknowns